• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2400436 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2024-07-09 Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd view
JYSB2500112 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products Supplementary Application 2025-05-01 Novo Nordisk A/S view
CXSL2400105 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2024-02-07 Tonghua Dongbao Pharmaceutical Co Ltd view
JXSS2000037 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.1) Import Drug Application 2020-09-30 诺和诺德(中国)制药有限公司 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S Certificate Issued 2021-08-27 view
CXSL2200411 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2022-08-29 Tonghua Dongbao Pharmaceutical Co Ltd view
CXSL2300092 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2023-02-08 The United Bio-Technology(Hengqin) Co Ltd view
CXSL2400082 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2024-02-01 Dongguan HEC Biopharmaceutical R&D Co Ltd;Sunshine Lake Pharma Co Ltd view
JXSS2000036 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.1) Import Drug Application 2020-09-30 诺和诺德(中国)制药有限公司 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S Certificate Issued 2021-10-28 view
CXSL2400772 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2024-11-13 Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd view
CYSB2300007 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products Supplementary Application 2023-01-11 Novo Nordisk (China) Pharmaceuticals Co Ltd view
JYSB2400021 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products Supplementary Application 2024-02-01 Novo Nordisk A/S view
CXSL2300515 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2023-07-26 Jilin Huisheng Biopharmaceutical Co Ltd view
JYSB2400035 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.1) Supplementary Application 2024-02-27 Novo Nordisk A/S view
JXSL1400054 德谷胰岛素/利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products Import Drug Application 2014-12-11 诺和诺德(中国)制药有限公司 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S Certificate Issued 2016-06-20 view
JYSZ2300038 利拉鲁肽注射液 liraglutide Injection Biological Products License Renew 2023-09-13 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
JYSB2000366 利拉鲁肽注射液 liraglutide Injection Biological Products(1) Supplementary Application 2020-08-07 诺和诺德(中国)制药有限公司 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S Filed 2020-08-17 view
JYSB1700197 利拉鲁肽注射液 liraglutide Injection Biological Products Supplementary Application 2017-11-17 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2017-12-21 view
JXSL0900064 利拉鲁肽注射液 liraglutide Injection Biological Products Import Drug Application 2009-09-04 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2011-03-15 view
CXSS2200064 利拉鲁肽注射液 liraglutide Injection Biological Products(3.2) New Drug Application 2022-07-14 Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd;Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd view
JXSS1800030 利拉鲁肽注射液 liraglutide Injection Biological Products Import Drug Application 2018-12-06 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2020-05-14 view